معرفی
Edward Kelly is a Professor and Adjunct Professor at the University of Washington, affiliated with the School of Pharmacy and the Department of Pharmaceutics, as well as the Environmental & Occupational Health Sciences. He is the Co-Director of the Pharmaceutical Bioengineering Program and leads the Kelly Lab, which focuses on microphysiological systems (organs-on-chips) for preclinical toxicology and drug metabolism research.
- Education: BS, MS, and PhD in Biochemistry from UC Riverside and the University of Washington.
His research interests center on ex vivo modeling of human organ physiology and toxicological responses to drugs and xenobiotics, with a focus on liver and kidney ADME organs. His lab is pioneering the use of organs-on-chips to replace animal testing (the 3 Rs) and study disease models and microgravity effects on the International Space Station.
His publications highlight the application of microphysiological systems in nephrotoxicity, drug metabolism, and multi-organ coupling. Key themes include toxicology, translational research, and biomedical engineering for preclinical models.
Edward Kelly teaches courses such as Biotechnology and Biopharmaceuticals, Drug Disposition Science, and Pharmacokinetics. His lab actively accepts students, and he collaborates with institutions like the Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute and the Program on Pharmacokinetics of Drugs of Abuse during Pregnancy (UWPKDAP).
